JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. Approved the establishment of the Company's subsidiary company detailed as follows: Establishment Date: To be completed within June 2023 Objectives: To invest in the services of academic laboratory research, scientific test and analysis, training and seminar, and consultancy for research fund application businesses of CDIP Registered Capital: Not exceeding THB 250 million Shareholding Structure: The Company will hold shares in the proportion of 100% of the registered capital.
JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.
Equities
JSP
THA520010002
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.5 THB | +3.31% | +5.93% | +8.70% |
1st Jan change | Capi. | |
---|---|---|
+8.70% | 32.29M | |
+48.39% | 779B | |
-6.13% | 354B | |
+20.61% | 333B | |
+10.00% | 301B | |
+18.87% | 249B | |
-1.96% | 216B | |
+11.11% | 214B | |
+5.80% | 163B | |
-2.50% | 159B |
- Stock Market
- Equities
- JSP Stock
- News JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.
- Jsp Pharmaceutical Manufacturing Public Co., Ltd. Approves the Establishment of the Company's Subsidiary